Summary

Patent Medicine Market Trends and Forecast
The future of the global patent medicine market looks promising with opportunities in the adult, children markets. The global patent medicine market is expected to grow with a CAGR of 7.4% from 2025 to 2031. The major drivers for this market are rising healthcare awareness, availability of online pharmacies, and increasing healthcare expenditure.

Lucintel forecasts that, within the type category, product patents is expected to witness higher growth over the forecast period due to the market for patented branded medicines is extensive.
Within the application category, adult is expected to witness the higher growth due to high prevalence of lifestyle-related conditions, chronic diseases.
In terms of region, North America is expected to witness the highest growth over the forecast period due to strong retail and online pharmacy networks, high healthcare spending.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Patent Medicine Market
The patent medicine market is evolving with new technological, regulatory, and consumer trends that are reshaping how medications are developed, protected, and marketed. The following trends highlight these shifts and their implications.
• Biologics and Biosimilar Expansion: Biologic medicines, which are derived from living organisms, are on the rise in the patent medicine market. As these medicines face patent expiration, biosimilar (nearly identical versions) are gaining traction. This trend is driving the development of affordable alternatives, especially in oncology and autoimmune diseases, where biologics are highly prevalent. The increasing adoption of biosimilar is expected to make patented treatments more affordable while maintaining treatment efficacy.
• Personalized Medicine: The rise of personalized medicine, which tailors treatments based on individual genetic profiles, is reshaping the patent medicine market. This trend is particularly significant in oncology and rare diseases, where precision therapies are crucial. As personalized medicine becomes more mainstream, pharmaceutical companies are focusing on developing and patenting innovative treatments that cater to specific patient profiles, ensuring higher success rates and better patient outcomes.
• Regulatory Reforms in Pricing and Market Access: Global regulatory reforms are influencing the patent medicine market, particularly in the areas of drug pricing and market access. Countries are increasingly implementing price control mechanisms, value-based pricing, and allowing for more flexible drug approval processes. These changes are affecting how patent-protected drugs are priced and distributed, making it more challenging for pharmaceutical companies to maintain high-profit margins but offering broader access to essential medicines.
• Patent Ever Greening: Patent ever greening, the strategy of making minor modifications to an existing patent to extend exclusivity, remains a contentious issue in the patent medicine market. While this practice allows companies to maintain monopoly pricing for extended periods, it has sparked debates regarding drug affordability and access. Regulatory bodies and healthcare organizations are scrutinizing this practice more closely, which could lead to new regulations or limitations on patent extensions.
• Focus on Rare and Orphan Drugs: The growing interest in rare and orphan diseases has led to an increase in the development of patented medicines targeting these conditions. As governments offer incentives such as market exclusivity and tax breaks, pharmaceutical companies are focusing on creating innovative treatments for conditions with limited treatment options. This has led to a rise in niche, high-cost medicines but has also spurred innovation in the patent medicine market, benefiting patients with rare diseases.
These emerging trends indicate that the patent medicine market is becoming increasingly complex and dynamic. The growth of biologics, personalized medicine, and regulatory reforms are creating new opportunities and challenges for pharmaceutical companies. Additionally, the focus on rare diseases and the ongoing debate around patent ever greening will continue to shape the development and accessibility of patented drugs in the coming years.

Recent Developments in the Patent Medicine Market
Recent developments in the patent medicine market reflect ongoing shifts in regulatory frameworks, technological innovations, and changing healthcare needs. These changes have profound effects on drug development, pricing, and distribution globally.
• Patent Expirations and Generic Alternatives: As patents on blockbuster drugs expire, the market has seen an influx of generic versions, leading to a reduction in prices. This trend is driving significant changes in the pharmaceutical industry, as patent-holding companies face increased competition from generics. While this benefits consumers, it places pressure on pharmaceutical companies to innovate and protect new products through additional patents.
• Increase in Biologic and Biosimilar Market: The biologic drug market is experiencing robust growth, with biologics becoming a major area of focus for pharmaceutical companies. As patents on biologics begin to expire, the biosimilar market is expanding rapidly, offering more affordable alternatives to high-cost biologic treatments. This shift is particularly evident in markets like the United States and Europe, where regulations for biosimilar are becoming more streamlined.
• Global Pricing and Access Reforms: Countries are increasingly implementing reforms to regulate the pricing of patented medicines, particularly for high-cost drugs. These reforms aim to make patented medicines more affordable, which is crucial in regions with large underserved populations. In countries like Germany, the United States, and India, policymakers are focusing on improving access to essential patented drugs through negotiation and price caps.
• Increased Focus on Rare Diseases: Pharmaceutical companies are directing more resources toward the development of treatments for rare diseases, a market where patented drugs often face little competition. Incentives such as extended exclusivity periods and fast-tracked approvals have fueled innovation in this space, creating high-value, niche markets for new treatments. As a result, the patent medicine market is becoming more specialized in addressing these unmet needs.
• Rise of Digital Health Solutions: Digital health platforms and telemedicine are becoming more integrated with patent medicine markets. Companies are increasingly incorporating digital tools to monitor patient adherence to patented therapies, especially in chronic conditions. This integration helps improve patient outcomes and provides pharmaceutical companies with data to improve their product offerings, driving further market growth.
These developments reflect the ongoing transformation of the patent medicine market. With the growing influence of biologics, the increasing focus on rare diseases, and global pricing reforms, pharmaceutical companies are facing both opportunities and challenges. The market is becoming more competitive, with innovation and regulatory changes driving the evolution of patent medicine offerings.

Strategic Growth Opportunities in the Patent Medicine Market
The patent medicine market presents several strategic growth opportunities, particularly in areas where innovation, regulatory changes, and healthcare needs are driving demand for new treatments.
• Biologics and Biosimilar: The expansion of biologics and biosimilar presents a significant opportunity for growth in the patent medicine market. With the expiration of patents on major biologic drugs, pharmaceutical companies can capitalize on the growing demand for affordable biosimilar. The market for biosimilar is expected to continue expanding as patients and healthcare providers seek cost-effective alternatives to expensive biologics.
• Targeted Cancer Therapies: The increasing demand for targeted cancer therapies offers growth potential for patented medicines. Pharmaceutical companies are focusing on developing precision medicines that target specific genetic mutations or pathways involved in cancer. This segment of the market is expected to expand rapidly as new discoveries in genomics and personalized medicine create opportunities for innovative cancer treatments.
• Regenerative Medicine: The field of regenerative medicine, including stem cell therapies and tissue engineering, presents a significant growth opportunity in the patent medicine market. These treatments are designed to repair or replace damaged tissues and organs, offering long-term solutions for conditions that were previously considered untreatable. The development of patented regenerative therapies is gaining momentum, especially for degenerative diseases.
• Rare Disease Treatments: As mentioned earlier, the focus on rare and orphan diseases presents a lucrative opportunity for pharmaceutical companies. The growth of orphan drug designations and government incentives is encouraging investment in treatments for diseases with limited therapeutic options. Patents on these drugs offer exclusivity, allowing companies to maintain high margins in a niche market.
• Digital Health Integration: The growing adoption of digital health technologies provides a unique opportunity for patent medicine manufacturers to integrate their products with digital tools. These tools can enhance patient adherence, improve treatment outcomes, and gather data to optimize future product development. As healthcare continues to embrace digital solutions, integrating medicine feeders with digital platforms will drive growth in the patent medicine market.
These strategic growth opportunities are reshaping the patent medicine market by focusing on high-value treatments and leveraging new technologies. By addressing the needs of patients with chronic conditions, rare diseases, and cancer, pharmaceutical companies can capitalize on the growing demand for personalized, biologic, and digital solutions.

Patent Medicine Market Driver and Challenges
The patent medicine market is shaped by a variety of technological, economic, and regulatory factors that both drive growth and present significant challenges. Technological innovations, regulatory reforms, and economic trends are creating opportunities for the development and distribution of patent-protected medications, especially as healthcare demands evolve. At the same time, challenges such as patent expirations, rising drug prices, and global accessibility concerns are influencing the market landscape. These drivers and challenges affect how pharmaceutical companies approach research and development, pricing, and market access, leading to a dynamic and competitive industry environment.
The factors responsible for driving the Patent Medicine market include:
1. Technological Advancements in Drug Development: Technological advancements, such as the rise of biotechnology and genomics, are pivotal drivers in the patent medicine market. The development of biologics, gene therapies, and personalized medicine allows pharmaceutical companies to create highly specialized treatments, many of which are patent-protected. These innovations have the potential to address previously untreatable diseases, driving market growth as they gain approval and commercial availability. However, these advancements often involve high research costs, making patent protection even more valuable as companies seek to recover investments and secure exclusivity in highly specialized markets.
2. Aging Global Population: The global aging population is a key driver of the patent medicine market, as older populations experience higher rates of chronic diseases, cancer, and other age-related conditions that require pharmaceutical intervention. This demographic shift is increasing demand for innovative treatments, particularly patented medicines that address complex or rare diseases. Pharmaceutical companies are investing in research to develop treatments tailored to this aging demographic, further driving the demand for new patent-protected drugs. As older populations grow, particularly in developed countries like Japan, Germany, and the United States, the market for these treatments is expected to expand.
3. Rising Healthcare Expenditures: As global healthcare expenditures rise, there is increasing demand for advanced medical treatments, including patented medicines. Governments, health systems, and insurance companies are investing in innovative treatments to improve patient outcomes and reduce the long-term costs of chronic diseases. This investment drives demand for high-value, patent-protected medicines. Additionally, increased spending on healthcare infrastructure and the rise of medical technology allow more patients to access new drugs, including those protected by patents. The growth of middle-class populations, particularly in emerging markets like China and India, also contributes to the expanding demand for patent medicines.
4. Regulatory Incentives for Drug Innovation: Governments around the world provide regulatory incentives to encourage innovation in drug development, such as extended patent exclusivity, market exclusivity, and fast-track approval processes for orphan drugs. These regulatory measures incentivize pharmaceutical companies to invest in the development of novel therapies, including biologics, vaccines, and rare disease treatments. For example, the Orphan Drug Act in the U.S. provides incentives for drugs targeting rare diseases, encouraging the creation of niche, high-value patented medicines. These regulatory mechanisms contribute to the market expansion by fostering a favorable environment for drug innovation.
5. Increase in Rare and Chronic Disease Treatments: The growing prevalence of rare and chronic diseases, including cancer, neurological disorders, and autoimmune diseases, has driven an increase in the development of patent medicines. Pharmaceutical companies are focusing on developing specialized treatments for these conditions, which often require cutting-edge therapies. Patents provide exclusivity and protection, allowing companies to recoup their investment in developing these highly specialized drugs. As more diseases are diagnosed and treatments become available, the demand for patented medicines is likely to continue to rise, particularly in oncology and genetic-based therapies.

Challenges in the Patent Medicine market are:
1. Patent Expirations and Generic Competition: One of the primary challenges facing the patent medicine market is the expiration of patents on blockbuster drugs. Once patents expire, generic alternatives enter the market, significantly reducing the revenue that original patent holders can generate from their medicines. Generic competition is particularly prevalent in the United States and Europe, where the demand for affordable medications is high.
2. Price Control and Government Regulation: Governments around the world are implementing price control measures to make patented medicines more affordable, especially in markets with high healthcare spending. These price regulations are often aimed at reducing the burden of expensive treatments on public health systems, but they can reduce profit margins for pharmaceutical companies. In countries like Germany and the U.S., policymakers are increasingly scrutinizing drug prices, which can limit the pricing flexibility that pharmaceutical companies rely on to recoup R&D costs.
3. Global Access and Affordability Issues: Despite innovations in drug development, many patients in low- and middle-income countries still lack access to patented medicines due to high costs and limited healthcare infrastructure. While some countries have policies to facilitate access, such as compulsory licensing or the use of generics, access remains a major issue. The disparity between wealthier nations and developing economies in accessing life-saving treatments, especially patented drugs, continues to challenge the global pharmaceutical market.
The patent medicine market is influenced by a blend of technological advancements, demographic trends, regulatory incentives, and challenges. Key drivers such as innovation in biologics, the aging population, and regulatory incentives are expanding market opportunities, while challenges like patent expirations, government price controls, and accessibility concerns in developing countries are creating barriers. Pharmaceutical companies must navigate these complexities to capitalize on growth opportunities while addressing the ongoing challenges that impact both profitability and patient access.

List of Patent Medicine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies patent medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the patent medicine companies profiled in this report include-
• Pfizer Inc.
• Otsuka Pharmaceutical
• Merck
• Novartis
• Sanofi-Aventis
• Bristol-Myers Squibb Co.
• GSK

Patent Medicine Market by Segment
The study includes a forecast for the global patent medicine market by type, application, and region.
Patent Medicine Market by Type [Value from 2019 to 2031]:
• Product Patents
• Process Patents

Patent Medicine Market by Application [Value from 2019 to 2031]:
• Adult
• Children

Patent Medicine Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Patent Medicine Market
The patent medicine market has witnessed dynamic changes in recent years, driven by factors such as innovation in drug formulation, increased consumer health awareness, and evolving regulations across global markets. Patent medicines, often manufactured by pharmaceutical companies with exclusive rights, represent a significant portion of the drug industry. In the United States, China, Germany, India, and Japan, regulatory developments, consumer trends, and technological advancements are shaping the market. These developments are impacting both established pharmaceutical companies and emerging players, influencing patent protection, drug availability, and pricing strategies in these key regions.
• United States: In the United States, the patent medicine market has experienced several key developments, including growing concerns over drug pricing and patent expirations. The market is shifting toward increased scrutiny of pharmaceutical patents, with efforts to address high drug costs through policy changes such as the Inflation Reduction Act, which empowers Medicare to negotiate certain drug prices. Additionally, patent litigation has intensified with the rise of generic drug manufacturers challenging patents. Furthermore, the emergence of biologics and biosimilar is reshaping the market dynamics, offering more affordable alternatives to patented medications.
• China: China’s patent medicine market is expanding rapidly due to the country’s growing middle class and increasing healthcare investments. The government has introduced policies aimed at improving access to patented medicines, including price reforms and accelerated drug approval processes. China’s regulatory environment is evolving with greater emphasis on intellectual property rights, providing stronger protections for pharmaceutical patents. The country is also a significant player in the global generics market, which is challenging the dominance of patented medicines. Increasing domestic innovation, particularly in biotechnology and traditional Chinese medicine, is driving the growth of patent-protected medicines.
• Germany: Germany’s patent medicine market is heavily regulated, with the government implementing strict pricing controls on patented medicines. The market is undergoing significant changes as patients increasingly demand high-quality treatments, particularly for chronic and complex diseases. The rise of personalized medicine and biologics has led to increased demand for patented therapies. Germany's healthcare system ensures that patented medicines are reimbursed through statutory health insurance, influencing pricing and accessibility. Furthermore, the country’s efforts to curb the high cost of patented drugs through price negotiations are a crucial focus, impacting the availability and affordability of these medicines.
• India: India's patent medicine market faces unique challenges due to its large population and significant demand for affordable healthcare. Patent laws in India are stringent, with the country offering compulsory licensing for certain essential medicines, particularly those that are unaffordable to the masses. The market is influenced by the growing adoption of generic medicines, often as an alternative to expensive patented drugs. However, the growing pharmaceutical industry is also seeing innovations in patented medicines, especially in oncology and biotechnology. India’s active pharmaceutical sector, combined with international partnerships, is expected to continue driving growth in the patent medicine market.
• Japan: Japan’s patent medicine market is characterized by an aging population, leading to increased demand for both patented and generic drugs. The government’s pharmaceutical policies emphasize access to innovative treatments, including rare disease therapies, and are focusing on reducing the high costs of patented medicines. Patent protection in Japan is strong, with a robust legal system in place to defend pharmaceutical patents. In addition, the country is increasingly focusing on regenerative medicine and biopharmaceuticals, where patents play a critical role in protecting intellectual property. The growing acceptance of biosimilar is also reshaping the landscape of patent medicines in Japan.

Features of the Global Patent Medicine Market
Market Size Estimates: Patent medicine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Patent medicine market size by type, application, and region in terms of value ($B).
Regional Analysis: Patent medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the patent medicine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the patent medicine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the patent medicine market by type (product patents and process patents), application (adult and children), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents

Table of Contents

1. Executive Summary

2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis
3.1 Global Patent Medicine Market Trends and Forecast
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Patent Medicine Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Product Patents: Trends and Forecast (2019-2031)
4.4 Process Patents: Trends and Forecast (2019-2031)

5. Global Patent Medicine Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Adult: Trends and Forecast (2019-2031)
5.4 Children: Trends and Forecast (2019-2031)

6. Regional Analysis
6.1 Overview
6.2 Global Patent Medicine Market by Region

7. North American Patent Medicine Market
7.1 Overview
7.2 North American Patent Medicine Market by type
7.3 North American Patent Medicine Market by application
7.4 United States Patent Medicine Market
7.5 Mexican Patent Medicine Market
7.6 Canadian Patent Medicine Market

8. European Patent Medicine Market
8.1 Overview
8.2 European Patent Medicine Market by type
8.3 European Patent Medicine Market by application
8.4 German Patent Medicine Market
8.5 French Patent Medicine Market
8.6 Spanish Patent Medicine Market
8.7 Italian Patent Medicine Market
8.8 United Kingdom Patent Medicine Market

9. APAC Patent Medicine Market
9.1 Overview
9.2 APAC Patent Medicine Market by type
9.3 APAC Patent Medicine Market by application
9.4 Japanese Patent Medicine Market
9.5 Indian Patent Medicine Market
9.6 Chinese Patent Medicine Market
9.7 South Korean Patent Medicine Market
9.8 Indonesian Patent Medicine Market

10. ROW Patent Medicine Market
10.1 Overview
10.2 ROW Patent Medicine Market by type
10.3 ROW Patent Medicine Market by application
10.4 Middle Eastern Patent Medicine Market
10.5 South American Patent Medicine Market
10.6 African Patent Medicine Market

11. Competitor Analysis
11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter’s Five Forces Analysis
• Competitive Rivalry
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Threat of Substitutes
• Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis
12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
12.2.1 Growth Opportunities by Type
12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Patent Medicine Market
12.4 Strategic Analysis
12.4.1 New Product Development
12.4.2 Certification and Licensing
12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain
13.1 Competitive Analysis
13.2 Pfizer Inc.
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.3 Otsuka Pharmaceutical
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.4 Merck
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.5 Novartis
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.6 Sanofi-Aventis
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.7 Bristol-Myers Squibb Co.
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.8 GSK
• Company Overview
• Patent Medicine Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing

14. Appendix
14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

List of Figures

Chapter 1
Figure 1.1: Trends and Forecast for the Global Patent Medicine Market
Chapter 2
Figure 2.1: Usage of Patent Medicine Market
Figure 2.2: Classification of the Global Patent Medicine Market
Figure 2.3: Supply Chain of the Global Patent Medicine Market
Chapter 3
Figure 3.1: Driver and Challenges of the Patent Medicine Market
Figure 3.2: PESTLE Analysis
Figure 3.3: Patent Analysis
Figure 3.4: Regulatory Environment
Chapter 4
Figure 4.1: Global Patent Medicine Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Patent Medicine Market ($B) by Type
Figure 4.3: Forecast for the Global Patent Medicine Market ($B) by Type
Figure 4.4: Trends and Forecast for Product Patents in the Global Patent Medicine Market (2019-2031)
Figure 4.5: Trends and Forecast for Process Patents in the Global Patent Medicine Market (2019-2031)
Chapter 5
Figure 5.1: Global Patent Medicine Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Patent Medicine Market ($B) by Application
Figure 5.3: Forecast for the Global Patent Medicine Market ($B) by Application
Figure 5.4: Trends and Forecast for Adult in the Global Patent Medicine Market (2019-2031)
Figure 5.5: Trends and Forecast for Children in the Global Patent Medicine Market (2019-2031)
Chapter 6
Figure 6.1: Trends of the Global Patent Medicine Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Patent Medicine Market ($B) by Region (2025-2031)
Chapter 7
Figure 7.1: North American Patent Medicine Market by type in 2019, 2024, and 2031
Figure 7.2: Trends of the North American Patent Medicine Market ($B) by type (2019-2024)
Figure 7.3: Forecast for the North American Patent Medicine Market ($B) by type (2025-2031)
Figure 7.4: North American Patent Medicine Market by application in 2019, 2024, and 2031
Figure 7.5: Trends of the North American Patent Medicine Market ($B) by application (2019-2024)
Figure 7.6: Forecast for the North American Patent Medicine Market ($B) by application (2025-2031)
Figure 7.7: Trends and Forecast for the United States Patent Medicine Market ($B) (2019-2031)
Figure 7.8: Trends and Forecast for the Mexican Patent Medicine Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Canadian Patent Medicine Market ($B) (2019-2031)
Chapter 8
Figure 8.1: European Patent Medicine Market by type in 2019, 2024, and 2031
Figure 8.2: Trends of the European Patent Medicine Market ($B) by type (2019-2024)
Figure 8.3: Forecast for the European Patent Medicine Market ($B) by type (2025-2031)
Figure 8.4: European Patent Medicine Market by application in 2019, 2024, and 2031
Figure 8.5: Trends of the European Patent Medicine Market ($B) by application (2019-2024)
Figure 8.6: Forecast for the European Patent Medicine Market ($B) by application (2025-2031)
Figure 8.7: Trends and Forecast for the German Patent Medicine Market ($B) (2019-2031)
Figure 8.8: Trends and Forecast for the French Patent Medicine Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the Spanish Patent Medicine Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Italian Patent Medicine Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the United Kingdom Patent Medicine Market ($B) (2019-2031)
Chapter 9
Figure 9.1: APAC Patent Medicine Market by type in 2019, 2024, and 2031
Figure 9.2: Trends of the APAC Patent Medicine Market ($B) by type (2019-2024)
Figure 9.3: Forecast for the APAC Patent Medicine Market ($B) by type (2025-2031)
Figure 9.4: APAC Patent Medicine Market by application in 2019, 2024, and 2031
Figure 9.5: Trends of the APAC Patent Medicine Market ($B) by application (2019-2024)
Figure 9.6: Forecast for the APAC Patent Medicine Market ($B) by application (2025-2031)
Figure 9.7: Trends and Forecast for the Japanese Patent Medicine Market ($B) (2019-2031)
Figure 9.8: Trends and Forecast for the Indian Patent Medicine Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Chinese Patent Medicine Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the South Korean Patent Medicine Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the Indonesian Patent Medicine Market ($B) (2019-2031)
Chapter 10
Figure 10.1: ROW Patent Medicine Market by type in 2019, 2024, and 2031
Figure 10.2: Trends of the ROW Patent Medicine Market ($B) by type (2019-2024)
Figure 10.3: Forecast for the ROW Patent Medicine Market ($B) by type (2025-2031)
Figure 10.4: ROW Patent Medicine Market by application in 2019, 2024, and 2031
Figure 10.5: Trends of the ROW Patent Medicine Market ($B) by application (2019-2024)
Figure 10.6: Forecast for the ROW Patent Medicine Market ($B) by application (2025-2031)
Figure 10.7: Trends and Forecast for the Middle Eastern Patent Medicine Market ($B) (2019-2031)
Figure 10.8: Trends and Forecast for the South American Patent Medicine Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the African Patent Medicine Market ($B) (2019-2031)
Chapter 11
Figure 11.1: Porter’s Five Forces Analysis of the Global Patent Medicine Market
Figure 11.2: Market Share (%) of Top Players in the Global Patent Medicine Market (2024)
Chapter 12
Figure 12.1: Growth Opportunities for the Global Patent Medicine Market by Type
Figure 12.2: Growth Opportunities for the Global Patent Medicine Market by Application
Figure 12.3: Growth Opportunities for the Global Patent Medicine Market by Region
Figure 12.4: Emerging Trends in the Global Patent Medicine Market

List of Tables

Chapter 1
Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Patent Medicine Market by Type and Application
Table 1.2: Attractiveness Analysis for the Patent Medicine Market by Region
Table 1.3: Global Patent Medicine Market Parameters and Attributes
Chapter 3
Table 3.1: Trends of the Global Patent Medicine Market (2019-2024)
Table 3.2: Forecast for the Global Patent Medicine Market (2025-2031)
Chapter 4
Table 4.1: Attractiveness Analysis for the Global Patent Medicine Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Patent Medicine Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Patent Medicine Market (2025-2031)
Table 4.4: Trends of Product Patents in the Global Patent Medicine Market (2019-2024)
Table 4.5: Forecast for Product Patents in the Global Patent Medicine Market (2025-2031)
Table 4.6: Trends of Process Patents in the Global Patent Medicine Market (2019-2024)
Table 4.7: Forecast for Process Patents in the Global Patent Medicine Market (2025-2031)
Chapter 5
Table 5.1: Attractiveness Analysis for the Global Patent Medicine Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Patent Medicine Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Patent Medicine Market (2025-2031)
Table 5.4: Trends of Adult in the Global Patent Medicine Market (2019-2024)
Table 5.5: Forecast for Adult in the Global Patent Medicine Market (2025-2031)
Table 5.6: Trends of Children in the Global Patent Medicine Market (2019-2024)
Table 5.7: Forecast for Children in the Global Patent Medicine Market (2025-2031)
Chapter 6
Table 6.1: Market Size and CAGR of Various Regions in the Global Patent Medicine Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Patent Medicine Market (2025-2031)
Chapter 7
Table 7.1: Trends of the North American Patent Medicine Market (2019-2024)
Table 7.2: Forecast for the North American Patent Medicine Market (2025-2031)
Table 7.3: Market Size and CAGR of Various type in the North American Patent Medicine Market (2019-2024)
Table 7.4: Market Size and CAGR of Various type in the North American Patent Medicine Market (2025-2031)
Table 7.5: Market Size and CAGR of Various application in the North American Patent Medicine Market (2019-2024)
Table 7.6: Market Size and CAGR of Various application in the North American Patent Medicine Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Patent Medicine Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Patent Medicine Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Patent Medicine Market (2019-2031)
Chapter 8
Table 8.1: Trends of the European Patent Medicine Market (2019-2024)
Table 8.2: Forecast for the European Patent Medicine Market (2025-2031)
Table 8.3: Market Size and CAGR of Various type in the European Patent Medicine Market (2019-2024)
Table 8.4: Market Size and CAGR of Various type in the European Patent Medicine Market (2025-2031)
Table 8.5: Market Size and CAGR of Various application in the European Patent Medicine Market (2019-2024)
Table 8.6: Market Size and CAGR of Various application in the European Patent Medicine Market (2025-2031)
Table 8.7: Trends and Forecast for the German Patent Medicine Market (2019-2031)
Table 8.8: Trends and Forecast for the French Patent Medicine Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Patent Medicine Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Patent Medicine Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Patent Medicine Market (2019-2031)
Chapter 9
Table 9.1: Trends of the APAC Patent Medicine Market (2019-2024)
Table 9.2: Forecast for the APAC Patent Medicine Market (2025-2031)
Table 9.3: Market Size and CAGR of Various type in the APAC Patent Medicine Market (2019-2024)
Table 9.4: Market Size and CAGR of Various type in the APAC Patent Medicine Market (2025-2031)
Table 9.5: Market Size and CAGR of Various application in the APAC Patent Medicine Market (2019-2024)
Table 9.6: Market Size and CAGR of Various application in the APAC Patent Medicine Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Patent Medicine Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Patent Medicine Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Patent Medicine Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Patent Medicine Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Patent Medicine Market (2019-2031)
Chapter 10
Table 10.1: Trends of the ROW Patent Medicine Market (2019-2024)
Table 10.2: Forecast for the ROW Patent Medicine Market (2025-2031)
Table 10.3: Market Size and CAGR of Various type in the ROW Patent Medicine Market (2019-2024)
Table 10.4: Market Size and CAGR of Various type in the ROW Patent Medicine Market (2025-2031)
Table 10.5: Market Size and CAGR of Various application in the ROW Patent Medicine Market (2019-2024)
Table 10.6: Market Size and CAGR of Various application in the ROW Patent Medicine Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Patent Medicine Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Patent Medicine Market (2019-2031)
Table 10.9: Trends and Forecast for the African Patent Medicine Market (2019-2031)
Chapter 11
Table 11.1: Product Mapping of Patent Medicine Suppliers Based on Segments
Table 11.2: Operational Integration of Patent Medicine Manufacturers
Table 11.3: Rankings of Suppliers Based on Patent Medicine Revenue
Chapter 12
Table 12.1: New Product Launches by Major Patent Medicine Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Patent Medicine Market